Zhongchao
Business Services · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Oocl Tower 841 Yan'an Middle Rd Rm 2504,...Phone Number
+86 2132205987Website
www.izcmd.comRevenue
$11.4 MillionStock Symbol
ZCMDIndustry
About Zhongchao
Zhongchao Org Chart
Is Zhongchao your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Zhongchao has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Zhongchao launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Zhongchao is spiking on competitors!
Funding: Get notified immidiatlly once Zhongchao has new funding data
Congratulate Masked Content for being promoted to Masked Content at Zhongchao
Click to see if Zhongchao had a recent Job posting/layoffs
Earning: See what the market has to say on Zhongchao recently announced quarterly report
Zhongchao, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Zhongchao
Find 2 more new buyers
Company Profile Activity
Activity Insights
Zhongchao is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Zhongchao is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Zhongchao.
Zhongchao Tech Stack
A closer look at the technologies used by Zhongchao
Zhongchao News & Media
Zhongchao Inc. Announces 1-for-31 Share Consolidation
SHANGHAI, June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-31 share consolidation of the Company's ordinary shares of US$0.008 par value each (the "Share Consolidation"). Beginning with the opening of trading on June 8, 2026, the Company's Class A ordinary shares will begin trading on aZhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the pricing of a best efforts public offering with gross...Zhongchao Inc. Announces 1-for-8 Share Consolidation
SHANGHAI, Feb. 26, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-8 share...Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, had successfully provided medication assistance services to over 7,000 low-income pati
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zhongchao
Incorporated in 2012 with headquarter offices in Shanghai and Beijing, China, Zhongchao Inc. is a platform-based internet technology company. It provides online healthcare information, professional training and educational services to healthcare professionals under its MDMOOC platform and to the public under its Sunshine Health Forums platform in C... Read More
